Institutional investors hold a majority ownership of BSX through the 93.17% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended December 2017, these large investors purchased a net $12.4 million shares.
Mutual fund holders | 57.77% |
Other institutional | 35.41% |
Individual stakeholders | 1.48% |